Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice (original) (raw)

• Sharp JA, Sung V, Slavin J, et al. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer. Lab Invest 1999; 79: 869–77.
  CAS PubMed Google Scholar
• Bellahcene A, Albert V, Pollina L, et al. Ectopic expression of bone sialoprotein in human thyroid cancer. Thyroid 1998; 8: 637–41.
  CAS PubMed Google Scholar
• Waltregny D, Bellahcene A, Van Riet I, et al. Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer. J Natl Cancer Inst 1998; 90: 1000–8.
  Article CAS PubMed Google Scholar
• Bellahcene A, Maloujahmoum N, Fisher LW et al. Expression of bone sialoprotein in human lung cancer. Calcif Tissue Int 1997; 61: 183–8.
  CAS PubMed Google Scholar
• Bellahcene A, Van Riet I, de Greef C et al. Bone sialoprotein mRNA and protein expression in human multiple myeloma cell lines and patients. Br J Haematol 2000; 111: 1118–21.
  Article CAS PubMed Google Scholar
• Bellahcene A, Menard S, Bufalino R, et al. Expression of bone sialoprotein in primary human breast cancer is associated with poor survival. Int J Cancer 1996; 69: 350–3.
  CAS PubMed Google Scholar
• Bellahcene A, Kroll M, Liebens F, et al.Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development. J Bone Miner Res 1996;11: 665–70.
  CAS PubMed Google Scholar
• Diel IJ. Prognostic factors for skeletal relapse in breast cancer.Cancer Treat Rev 2001; 27: 153–7; discussion 59-64.
  Article CAS PubMed Google Scholar
• Diel IJ, Solomayer EF, Seibel MJ et al. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis. Clin Cancer Res 1999;5: 3914–9.
  CAS PubMed Google Scholar
• Fedarko NS, Jain A, Karadag A et al. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res 2001; 7: 4060–6.
  CAS PubMed Google Scholar
• Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation.Cell 1991; 64: 327–36.
  Article CAS PubMed Google Scholar
• Sung V, Stubbs 3rd JT, Fisher L et al. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins. J Cell Physiol 1998; 176: 482–94.
  Article CAS PubMed Google Scholar
• Bellahcene A, Bonjean K, Fohr B et al. Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis. Circ Res 2000; 86: 885–91.
  CAS PubMed Google Scholar
• Colleoni M, O'Neill A, Goldhirsch A et al. Identifying breast cancer patients at high risk for bone metastases. J Clin Oncol 2000; 18: 3925–35.
  Google Scholar
• Yoneda T. Cellular and molecular basis of preferential metastasis of breast cancer to bone. J Orthop Sci 2000; 5: 75–81.
  Article CAS PubMed Google Scholar
• Martin TJ, Moseley JM.Mechanisms in the skeletal complications of breast cancer. Endocr Relat Cancer 2000; 7: 271–84.
  Article CAS PubMed Google Scholar
• Brunner N, Thompson EW, Spang-Thomsen M et al. LacZ transduced human breast cancer xenografts as an in vivo model for the study of invasion and metastasis. Eur J Cancer 1992; 28A: 1989–95.
  Article Google Scholar
• Fisher LW, McBride OW, Termine JD et al. Human bone sialoprotein. deduced protein sequence and chromosomal localization. J Biol Chem 1990; 265: 2347–51.
  CAS PubMed Google Scholar
• Miller DL, el-Ashry D, Cheville AL, et al. Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression. Cell Growth Differ 1994; 5: 1263–74.
  CAS PubMed Google Scholar
• Fisher LW, Stubbs J, Young MF. Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand 1995; 266: 61–5.
  CAS Google Scholar
• Thompson EW, Brunner N, Torri J et al. The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells. Clin Exp Metastasis 1993; 11: 15–26.
  Article CAS PubMed Google Scholar
• Skehan P, Storeng R, Scudiero D et al. New colorimetric cytotoxicity assay for anticancer-drug screening.J Natl Cancer Inst 1990; 82: 1107–12.
  CAS PubMed Google Scholar
• Price JT, Thompson EW. Models for studying cellular invasion of basement membranes. Meth Mol Biol 1999; 129: 231–49.
  CAS Google Scholar
• Tester AM, Ruangpanit N, Anderson RL et al. MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelio-mesenchymal transition traits. Clin Exp Metastasis 2001; 18: 553–60.
  Google Scholar
• Yu M, Sato H, Seiki M et al. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res 1995; 55: 3272–7.
  CAS PubMed Google Scholar
• Price JE, Polyzos A, Zhang RD et al. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 1990; 50: 717–21.
  CAS PubMed Google Scholar
• Arguello F, Baggs RB, Frantz CN. A murine model of experimental metastasis to bone and bone marrow. Cancer Res 1988; 48: 6876–81.
  CAS PubMed Google Scholar
• Sung V, Cattell DA, Bueno JM et al. Human breast cancer cell metastasis to long bone and soft organs of nude mice: A quantitative assay Clin Exp Metastesis 1997; 15:173–83.[published erratum appears in Clin Exp Metastasis 1997; 15(5): 553].
  CAS Google Scholar
• Tester A, Sharp JA, Dhanesuan N et al. Correlation between extent of osteolytic damage and metastatic burden of human breast cancer metastasis in nude mice: Real-time PCR quantitation. Clin ExpMetast 2002; 19:377–83.
  CAS Google Scholar
• Bellahcene A, Castronovo V. Expression of bone matrix proteins in human breast cancer: Potential roles in microcalcification formation and in the genesis of bone metastases. Bull Cancer 1997; 84: 17–24.
  CAS PubMed Google Scholar
• Gillespie MT, Thomas RJ, Pu ZY et al. Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers.Int J Cancer 1997; 73: 812–5.
  Article CAS PubMed Google Scholar
• Ibrahim T, Leong I, Sanchez-Sweatman O et al. Expression of bone sialoprotein and osteopontin in breast cancer bone metastases. Clin Exp Metastasis; 18: 253–60.
• Ronot X, Doisy A, Tracqui P. Quantitative study of dynamic behavior of cell monolayers during in vitro wound healing by optical flow analysis. Cytometry 2000; 41: 19–30.
  Article CAS PubMed Google Scholar
• Thompson EW, Paik S, Brunner N et al.Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 1992; 150: 534–44.
  Article CAS PubMed Google Scholar
• Stetler-Stevenson WG. Type IV collagenases in tumor invasion and metastasis.Cancer Metastasis Rev 1990; 9: 289–303.
  CAS PubMed Google Scholar
• Pulyaeva H, Bueno J, Polette M et al. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells.Clin Exp Metastasis 1997; 15:111–20.
  CAS PubMed Google Scholar
• Teti A, Farina AR, Villanova I et al. Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent. Int J Cancer 1998; 77: 82–93.
  Google Scholar
• Guise TA, Yin JJ, Taylor SD et al. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.J Clin Invest 1996; 98: 1544–9.
  CAS PubMed Google Scholar
• Partin AW, Schoeniger JS, Mohler JL et al. Fourier analysis of cell motility: Correlation of motility with metastatic potential. Proc Natl Acad Sci USA 1989; 86: 1254–8.
  CAS PubMed Google Scholar
• Raynal C, Delmas PD, Chenu C. Bone sialoprotein stimulates in vitro bone resorption. Endocrinology 1996;137:2347–54.
  Article CAS PubMed Google Scholar
• Oldberg A, Franzen A, Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an arg-gly-asp cell-binding sequence. Proc Natl Acad Sci USA 1986; 83: 8819–23.
  CAS PubMed Google Scholar
• van der Pluijm G, Vloedgraven HJ, Ivanov B et al. Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone. Cancer Res 1996; 56: 1948–55.
  CAS PubMed Google Scholar